Progressive Muscular Atrophy clinical trials at UC Health
2 research studies open to new patients

  • Answer ALS: Individualized Initiative for ALS Discovery

    open to eligible people ages 18-100

    Creation of a large repository of induced pluripotent stem cells (iPSC), bio-fluid samples (blood and spinal fluid (optional)), and cell lines for ALS gene identification. This will be combined carefully with collected measures of the pattern of the symptoms people with ALS have and how these change over time. People with other motor neuron diseases and healthy controls will be included as comparisons

    at UC Irvine

  • Phenotype, Genotype & Biomarkers in ALS and Related Disorders

    open to all eligible people

    The goals of this study are: (1) to better understand the relationship between the phenotype and genotype of amyotrophic lateral sclerosis (ALS) and related diseases, including primary lateral sclerosis (PLS), hereditary spastic paraplegia (HSP), progressive muscular atrophy (PMA), and frontotemporal dementia (FTD); and (2) to develop biomarkers that might be useful in aiding therapy development for this group of disorders.

    at UCSD

Last updated: